Indication
Hemophilia B with Inhibitor
5 clinical trials
4 products
Clinical trial
A Randomized, Open-label Study to Evaluate the Efficacy and Safety of KN057 Injection Prophylaxis in Patients With Hemophilia A or B With InhibitorsStatus: Recruiting, Estimated PCD: 2025-10-15
Product
KN057Clinical trial
A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With InhibitorsStatus: Recruiting, Estimated PCD: 2025-09-08
Clinical trial
An Open-label and Multicenter Phase Ib/II Clinical Trial to Evaluate the Safety, Immunogenicity, PK/PD Profile of SS109 and NovoSeven® Following a Single Dose, and the Preliminary Efficacy and Safety of SS109 During On-demand Treatment in Hemophilia Patients With Coagulation Factor VIII or IX InhibitorsStatus: Recruiting, Estimated PCD: 2024-05-31
Product
SS109Product
SerpinPCClinical trial
To Evaluate the Safety, PK/PD and Immunogenicity of SS109 in Hemophilia Patients With Blood Coagulation Factor Ⅷ or Ⅸ Inhibitors After Single Administration, Open Label, Dose Escalation, and Multicenter Phase I Clinical TrialStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With InhibitorsStatus: Recruiting, Estimated PCD: 2024-11-30